|
Market Closed -
NYSE
00:00:00 12/09/2026 +04
|
5-day change | 1st Jan Change | ||
| 21.90 USD | -2.36% |
|
-10.10% | -29.35% |
| 08-14 | Oppenheimer Adjusts Pelthos Therapeutics PT to $64 From $66, Maintains Outperform Rating | MT |
| 08-13 | Pelthos Therapeutics Inc., Q2 2026 Earnings Call, Aug 13, 2026 |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | -2.36% | -10.10% | -24.48% | -20.13% | -29.35% | -29.35% | - | - | - | 85.87M | |
| -0.65% | -3.79% | -9.44% | -1.82% | +3.82% | +47.85% | +90.24% | +365.85% | +1,326.00% | 1,001B | |
| -0.29% | -4.62% | +1.44% | +11.36% | +28.33% | +51.08% | +65.41% | +59.06% | +124.63% | 642B | |
| +0.83% | -1.19% | +3.69% | +14.30% | +12.53% | +21.49% | +72.54% | +141.02% | +305.81% | 451B | |
| -0.38% | -3.45% | -7.75% | +6.27% | +4.88% | +29.35% | +34.09% | +0.06% | +43.42% | 340B | |
| -0.09% | -14.68% | -11.64% | -5.88% | +2.23% | +11.22% | +27.14% | +42.42% | +44.75% | 263B | |
| -0.43% | -3.61% | -2.35% | -13.04% | -15.10% | -1.73% | +7.95% | +43.25% | +142.95% | 247B | |
| -1.34% | -15.03% | -9.55% | +11.73% | +15.29% | +35.49% | +45.45% | +76.54% | +126.57% | 207B | |
| -3.44% | -8.32% | -9.70% | -2.35% | -15.00% | -21.27% | -59.20% | -11.89% | +86.73% | 197B | |
| -0.75% | -4.96% | +8.01% | +18.31% | +17.09% | +24.70% | +89.11% | +102.45% | +84.14% | 180B | |
| +0.25% | -3.78% | +2.48% | +8.28% | +11.33% | +12.82% | -19.07% | -39.20% | -18.71% | 158B | |
| +0.17% | -7.62% | -1.62% | +18.30% | +13.69% | +32.66% | +50.25% | +173.34% | +450.21% | 130B | |
| -0.17% | -6.54% | -1.85% | +14.46% | +17.98% | +34.97% | +4.64% | +0.81% | +14.34% | 130B | |
| -0.42% | -3.95% | -3.01% | -3.62% | -11.44% | -8.74% | -26.99% | -10.52% | +4.14% | 102B | |
| -0.28% | -5.14% | -8.15% | -7.86% | -2.96% | +18.99% | +22.59% | -0.23% | -11.45% | 96.24B | |
| +0.06% | -6.63% | -9.70% | -15.05% | -22.09% | -3.56% | +44.06% | +53.82% | +462.51% | 68.56B | |
| +0.16% | -4.10% | +1.50% | +11.76% | +17.19% | +24.64% | +25.63% | +51.05% | +20.30% | 58.64B | |
| -1.09% | -2.37% | -2.15% | +36.19% | +30.15% | +71.85% | -4.02% | +5.23% | -49.31% | 55.63B | |
| -0.61% | -7.16% | -21.24% | -9.23% | -28.37% | -39.32% | +5.15% | -10.07% | +166.26% | 42.14B | |
| +2.04% | +1.28% | +2.63% | +10.45% | +18.84% | +89.52% | +285.55% | +303.59% | -26.13% | 42.36B | |
| Average | -0.42% | -5.17% | -5.14% | +4.12% | +3.45% | +20.13% | +40.03% | +70.87% | +173.53% | 220.54B | |
| Weighted average by Cap. | -0.36% | -4.68% | -4.13% | +4.69% | +7.86% | +29.37% | +49.79% | +126.11% | +398.64% |
- Stock Market
- Stocks
- PTHS Stock
- Sector Pelthos Therapeutics Inc.
Select your edition
All financial news and data tailored to specific country editions
